M. K. A. Tolba, K. A. E. Khashab, and A. S. A. Said, “THEEFFECT OF DIPEPTIDYL PEPTIDASE-4 INHIBITORS ON CARDIOVASCULAR DISEASE RISK IN TYPE 2 DIABETES MELLITUS”, Int J Pharm Pharm Sci, vol. 9, no. 1, pp. 254–259, Jan. 2017.